Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
15:46 | Blood Centers Complement Hospitals to Drive Cell and Gene Therapy Access | ||
03:46 | 7 ViVE Announcements You Don't Want to Miss | ||
00:46 | Millie Raises $12M to Advance Maternal Healthcare | ||
Do | AstraZeneca Secures China Rights to Anemia Drug, Buying FibroGen Unit in $160M Deal | ||
Do | The Future of Drug Discovery is 3D | ||
Do | How Can Healthcare Practices Cut Waste? | ||
Do | Recursion Pharma Accelerator Steps In to Fill Some of the Funding Gap Amid NIH Tumult | ||
Do | How Tampa General Hospital's Partnership with Palantir Is Shortening Its Innovation Timelines | ||
Mi | Attention Healthcare and Life Science Startups: Deadline for INVEST Pitch Perfect Contest Submissions is Feb 21 | ||
Mi | Aetna Taps InStride Health for Specialty Youth Mental Health | ||
Mi | Prioritizing Care That Cures - Fighting the Epidemic With Opioid Treatment Programs | ||
Mi | What Sets 2025's Digital Health Funding Environment Apart from Previous Years? | ||
Mi | Highmark Launches Virtual Pelvic Health Offering Powered by Sword Health | ||
Di | Ono Pharma Drug Acquired in $2.4B Deal Wins FDA Approval for Treating Rare Type of Tumor | ||
Di | Will the Entire NIH be Shut Down? | ||
Di | The Overlooked Pillar of Clinical Care: Physical Therapists | ||
Di | Memorial Sloan Kettering Teams Up with AWS to Speed Up Drug Discovery | ||
Mo | ViVE 2025: Shaping the Future of Virtual-first Care | ||
Mo | What Tufts, Kaiser Permanente and Others Hope to Achieve with the Food is Medicine National Network of Excellence | ||
Mo | Merck Is Embracing AI, But 'We Always Have a Human in the Loop,' Exec Says | ||
Mo | Why Aren't More Academic Medical Settings Using Generative AI Avatars to Train Future Doctors on Sensitivity? | ||
14.02. | Atria Health Launches National Partnership Model to Keep Cardiology Practices Independent | ||
14.02. | Midwest Health Purchasers Collaborative Taps Vida Health for Obesity Specialty Care | ||
14.02. | StartUPDATES: New Developments from Healthcare Startups | ||
14.02. | Bristol Myers Squibb Cancer Immunotherapy Flunks a Key Test in Melanoma |